AstraZeneca plc (LSE: AZN)

https://www.astrazeneca.com

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. *

	Start	1999-04-05 merged
	Group	AstraZeneca (Group)
	Industry	pharmaceutical

	Region	Cambridge, Cambridgeshire
	Country	United Kingdom (GB)
	Street	1 Francis Crick Avenue Cambridge Biomedical Campus
	City	CB2 0AA Cambridge, Cambridgeshire
		Address record changed: 2024-01-05

Basic data	Employees	I: 50,001 to 100,0 (2022-12-31)
	Currency	USD
	Annual sales	44,351,000,000 (revenue, total, consolidated (2022) 2022-12-31)
	Profit	3,293,000,000 (2022-12-31)
	Cash	6,166,000,000 (2022-12-31)

		* Document for »About Section«: AstraZeneca plc. (11/29/22). "Press Release: AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy".

		Record changed: 2024-09-11

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for AstraZeneca (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com